Sign inJoin waitlistJoin the waitlist

SM

Sabeen Mekan

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2018 · 3,758 citations
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised,…
The Lancet Oncology · 2019 · 646 citations
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
The Lancet Oncology · 2019 · 198 citations

Brian Rini
3 papers
Hans Hammers
3 papers
Marina Garassino
3 papers
RM
Robert Motzer
3 papers
Saby George
3 papers
TongFan Wu
3 papers · 3 as a resident
David McDermott
2 papers
DR
Douglas Reznick
2 papers
Ecaterina Dumbrava
2 papers
Edward Garon
2 papers
Elizabeth Plimack
2 papers
FB
Firas Badin
2 papers